HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
HCW Biologics Inc. announced the adjournment of its Special Meeting of Stockholders held on April 27, 2026, due to insufficient quorum, postponing the approval of proposals regarding warrants issued to Armistice Capital Master Fund Ltd. The matters will be addressed at the Annual Meeting scheduled for June 15, 2026. This ongoing delay obliges the c…